GlassScriptPhysician profile
Deborah Kolb
NPI 1063493153
$1,500.62
in general payments reported to CMS, 2019-2025
17 companies · $43.90 in 2025
The $43.90 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $505 · 2020: $196 · 2021: $291 · 2022: $239 · 2023: $160 · 2024: $66.17 · 2025: $43.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $270.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $420.62 | 2019-2024 | Farxiga |
| Glaxosmithkline, LLC. | $282.67 | 2019-2023 | Shingrix, Arexvy |
| Abbvie INC. | $225.28 | 2019-2024 | |
| Lilly USA, LLC | $179.70 | 2020-2025 | Mounjaro, Zepbound |
| Takeda Pharmaceuticals U.S.A., INC. | $71.34 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $68.52 | 2019-2024 | Gardasil 9, Gardasil, Capvaxive |
| Novo Nordisk INC | $57.85 | 2021-2023 | Ozempic, Rybelsus |
| Abbott Laboratories | $40.14 | 2022 | |
| Genentech USA, INC. | $34.71 | 2019-2020 | |
| Aimmune Therapeutics, INC. | $24.52 | 2021 | |
| Sanofi Pasteur INC. | $15.37 | 2019 | |
| Astellas Pharma US INC | $15.06 | 2023 | Myrbetriq |
| Esperion Therapeutics, INC. | $14.34 | 2020 | |
| Pfizer INC. | $13.45 | 2022 | |
| Amgen INC. | $12.85 | 2023 | Repatha, Otezla |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $12.62 | 2020 | |
| Amarin Pharma, INC. | $11.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Kolb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.